1 The Simvastatin Pravastatin Study Group. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. Am J Cardiol, 1993, 71(16)：1408
2 Scandinavian Simvastatin Survival study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease： the Sandinavian Simvastatin Survival Study (4s). Lancet, 1994, 344:1383
3 Todd PA, Goa KL. Simvastatin: A review of its pharmacological properties and therapentic potential in hypercholesterolemia. Drugs, 1990, 40:583
4 Foley DP. Bonnier H, Jackson G, et al. Prevention of restenosis after coronary balloon angioplasty： rational (FIARE) trial. Am J Cardiol, 1994, 73:540
5 The MAAS investigators. Effect of simvastatin on coronary atheroma: the Multicenter Anti 一 Atheroma Study (MAAS). Lancet, 1994, 334:633
6 Mol MJ, Erkelens DW, Gevers Leuven JA, et at. Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolemia. Lancet, 1986, II: 936
7 Ducobu J, Low dose (5mg) simvastation verus gemfibrozil in the treatment of primary moderate hypercholesterolemia: Result of a Belgian Multicenter Study. Curr Ther Res, 1989, 46:144
8 Pietro DA, Alexander St Mantell G, et al. Effects of simvastatin and probucol in hypercholesterolemia (Simvastatim Multicenter study Group II) . Am J Cardiol, 1989, 63(11)；682
9 Stalenhoef AF, Mol MJ, Stuyt PM. Efficacy and tolerability of simvastatin (MK-733). Am J Med, 1989, 87(4A)：39s
10 Blum CB. Comparism of properties of four inhibitors of 3-hydroxy-3-methylglutary ~ coenzyme A rednc-tase. Am J Cardiol, 1994, 73：54D
11 Havel RJ, Hunninghake DB. Illingworth DR, et al. Lovastatin (Mevinolin) in the treatment of heterozygons familial hyperoholesterolemia. Ann Intern Med, 1987, 107:609
12 Kjekshus J, Pedersen TR. Reducing the risk of coronary events： evidence from the Scandinavian simvastatin survival study (4s). Am J cardiol, 1995, 76；64c
13 Cobbe SM, Shepherd J. Cholesterol reductiuri in the prevention of coronary heart disease： therapentic rationale and gnidelines. br Heart J, 1993, 69:S63
14 Pedersen TR, Kjekshus J. Olsson AG, et al. Scandinavian Simvastatin Survival Study (4s). (letter), Lancet, 1994, 344：1767
15 Boccuzzi SJ. Long term experience with simvastatin Drug Invest, 1993, 5(2):135
16 Newman TB, Hulley SB, Carcinogenicity oi lipid-lowering. JAMA, 1996, 275:55
17 Dalen JE, Dalton WS. Does lowering cholesterol Canse Cancer ? JAMA, 1996, 275:67 |
